Citizens Financial Group Inc Johnson & Johnson Transaction History

Citizens Financial Group Inc

$4.91 Billion
Q3 2024

A detailed history of Citizens Financial Group Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Citizens Financial Group Inc holds 174,461 shares of JNJ stock, worth $25.2 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares

174,461

Previous 180,501 3.35%

Holding current value

$25.2 Million

Previous $26.4 Million 7.17%

% of portfolio

0.58%

Previous 0.59%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$145.48 - $167.38 $878,699 - $1.01 Million	-6,040 Reduced 3.35%	174,461 $28.3 Million
Q2 2024 Aug 09, 2024	BUY	$144.38 - $157.78 $11.8 Million - $12.9 Million	81,780 Added 82.84%	180,501 $26.4 Million
Q1 2024 May 17, 2024	SELL	$155.22 - $162.74 $1.38 Million - $1.44 Million	-8,868 Reduced 8.24%	98,721 $15.6 Million
Q4 2023 Feb 02, 2024	BUY	$145.6 - $158.88 $721,302 - $787,091	4,954 Added 4.83%	107,589 $16.9 Million
Q3 2023 Nov 13, 2023	SELL	$155.75 - $174.48 $3.93 Million - $4.41 Million	-25,247 Reduced 19.74%	102,635 $16 Million
Q2 2023 Aug 04, 2023	SELL	$154.35 - $166.11 $1.1 Million - $1.18 Million	-7,128 Reduced 5.28%	127,882 $21.2 Million
Q1 2023 May 10, 2023	BUY	$151.05 - $180.26 $8.06 Million - $9.62 Million	53,387 Added 65.41%	135,010 $20.9 Million
Q4 2022 Feb 09, 2023	SELL	$160.2 - $179.79 $133,126 - $149,405	-831 Reduced 1.01%	81,623 $14.4 Million
Q3 2022 Nov 10, 2022	SELL	$161.33 - $179.52 $97,120 - $108,071	-602 Reduced 0.72%	82,454 $13.5 Million
Q2 2022 Aug 05, 2022	SELL	$168.19 - $186.01 $741,717 - $820,304	-4,410 Reduced 5.04%	83,056 $14.7 Million
Q1 2022 May 12, 2022	SELL	$158.14 - $179.59 $811,574 - $921,655	-5,132 Reduced 5.54%	87,466 $15.5 Million
Q4 2021 Feb 10, 2022	BUY	$155.93 - $173.01 $115,700 - $128,373	742 Added 0.81%	92,598 $15.4 Million
Q3 2021 Nov 05, 2021	BUY	$161.5 - $179.47 $794,741 - $883,171	4,921 Added 5.66%	91,856 $14.8 Million
Q2 2021 Aug 04, 2021	BUY	$159.48 - $171.07 $682,095 - $731,666	4,277 Added 5.17%	86,935 $14.3 Million
Q1 2021 May 14, 2021	BUY	$153.07 - $170.48 $1.09 Million - $1.21 Million	7,109 Added 9.41%	82,658 $13.6 Million
Q4 2020 Feb 11, 2021	SELL	$137.11 - $157.38 $9.06 Million - $10.4 Million	-66,085 Reduced 46.66%	75,549 $11.9 Million
Q3 2020 Nov 12, 2020	SELL	$140.38 - $153.83 $946,863 - $1.04 Million	-6,745 Reduced 4.55%	141,634 $21.1 Million
Q2 2020 Aug 12, 2020	SELL	$128.81 - $155.51 $146,585 - $176,970	-1,138 Reduced 0.76%	148,379 $20.9 Million
Q1 2020 May 08, 2020	BUY	$111.14 - $153.99 $1.03 Million - $1.42 Million	9,227 Added 6.58%	149,517 $19.6 Million
Q4 2019 Feb 07, 2020	SELL	$127.5 - $146.44 $161,542 - $185,539	-1,267 Reduced 0.9%	140,290 $20.5 Million
Q3 2019 Nov 01, 2019	SELL	$126.95 - $142.14 $396,591 - $444,045	-3,124 Reduced 2.16%	141,557 $18.3 Million
Q2 2019 Aug 09, 2019	SELL	$131.15 - $144.24 $402,630 - $442,816	-3,070 Reduced 2.08%	144,681 $20.2 Million
Q1 2019 May 09, 2019	BUY	$125.72 - $139.79 $181,162 - $201,437	1,441 Added 0.98%	147,751 $20.7 Million
Q4 2018 Feb 11, 2019	SELL	$122.84 - $147.84 $106,502 - $128,177	-867 Reduced 0.59%	146,310 $18.9 Million
Q3 2018 Nov 02, 2018	SELL	$121.58 - $142.88 $564,739 - $663,677	-4,645 Reduced 3.06%	147,177 $20.3 Million
Q2 2018 Jul 27, 2018	SELL	$119.4 - $131.76 $400,945 - $442,450	-3,358 Reduced 2.16%	151,822 $18.4 Million
Q1 2018 May 11, 2018	SELL	$125.1 - $148.14 $1.14 Million - $1.35 Million	-9,080 Reduced 5.53%	155,180 $19.9 Million
Q4 2017 Feb 09, 2018	SELL	$131.22 - $143.62 $88,048 - $96,369	-671 Reduced 0.41%	164,260 $23 Million
Q3 2017 Nov 13, 2017	SELL	$129.47 - $135.38 $58,132 - $60,785	-449 Reduced 0.27%	164,931 $21.4 Million
Q2 2017 Aug 10, 2017	BUY	N/A	165,380	165,380 $21.9 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $378B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citizens Financial Group Inc with notifications on news.

Account

Citizens Financial Group Inc Johnson & Johnson Transaction History